Pfizer And Drug Pricing: Should You Invest Now? May 15, 2025 — 01:55 am EDT. ... At its current price of $23, Pfizer stock trades at just 8 times trailing earnings of $2.91 per share.

No Drug Price Pledges by Pfizer, Others in Talks With US Government, Pfizer CEO Says. More. Reuters. FILE PHOTO: Pfizer logo is seen in this illustration taken, May 1, 2022.

Pfizer Inc. (PFE) CEO Albert Bourla has reportedly said that the company has made no commitments during its meeting with the Trump administration to discuss lowering U.S. drug prices. Bourla said ...

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...

Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug manufacturers, had a meeting with the Trump administration to talk about reducing US ...

Pfizer faces a $1 billion sales hit in 2025 from IRA reforms, flat EPS and revenue forecasts, and long-term risks tied to patent expirations.

Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...

Trump's so-called “most favored nation” approach to Medicare drug pricing has been controversial since he ... by Medicare and Medicaid because it can set regulations. ... Pfizer, which notched ...

(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.